✦ LIBER ✦

650 - Taxotere™ (docetaxel, D), doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in the treatment of metastatic breast cancer (MBC)

✍ Scribed by J.-M. Nabholtz; M. Smyllo; J.R. Mackey; A. Paterson; D. Noel; T. Al-Twelgerl; D. Au; E. Sansregret; F. Delorme; A. Riva

Book ID: 117664897
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 267 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)85225-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P953. Phase II study of taxotere® (Docet

P953. Phase II study of taxotere® (Docetaxel, D), Doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in the treatment of metastatic breast cancer (MBC)

✍ J.-M. Nabholtz; J.R. Mackey; M. Smylie; A. Paterson; D. Noel; T. Al-Tweigeri; F. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Final results of a phase II study of Tax

Final results of a phase II study of Taxotere (docetaxel, D), doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in thétreatment of metastatic breast cancer (MBC)

✍ J.-M. Nabholtz; J.R. Mackey; M. Simylie; A. Paterson; D. Noel; T. Al-Twelgeri; A 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Taxotere® (T) and doxorubicin (D) combin

Taxotere® (T) and doxorubicin (D) combination: a phase II South American study in first line treatment (tt) of metastatic breast cancer (MBC)

✍ Vallejos, C.; Nunez, P.; Orlandi, L.; Carranza, H.; Fodor, M.; Reyes, J.M.; Majl 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Sequential multiagent chemotherapy incor

Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer

✍ Richard L. Theriault; Gabriel N. Hortobagyi; Shu W. Kau; Frankie A. Holmes; Vere 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Forty-three consecutive patients with metastatic breast cancer and clearly measurable disease were treated with sequential multiagent chemotherapy. Therapy consisted of the administration in fixed sequence of cisplatin, doxorubicin, and cyclophosphamide (PAC) (four cycles), vinbbtine, doxorubicin, a

Phase I study of an all-oral combination

Phase I study of an all-oral combination of vinorelbine (VRL) and cyclophosphamide (Ctx) as second line treatment in patients with metastatic breast cancer (MBC)

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Phase III study of liposome-encapsulated

Phase III study of liposome-encapsulated doxorubicin (TLC D-99) and cyclophosphamide (CPA) vs. epirubicin (EPI) and CPA in first-line treatment of metastatic breast cancer (MBC)

✍ Chan, S.; Davidson, N.; Juozaityte, E.; Erdkamp, F.; Hooftman, L.; Azarnia, N. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 111 KB